Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Clonal chromosomal abnormalities in CD34 CD38 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitorsBUMM, T ; DEININGER, J ; NEWELL, A. H ; LAWCE, H ; OLSON, S ; MAURO, M ; DRUKER, B ; DEININGER, MLeukemia, 2010-08, Vol.24 (8), p.1525-1528 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemiaTyner, J W ; Loriaux, M M ; Erickson, H ; Eide, C A ; Deininger, J ; MacPartlin, M ; Willis, S G ; Lange, T ; Druker, B J ; Kovacsovics, T ; Maziarz, R ; Gattermann, N ; Deininger, M WLeukemia, 2009-02, Vol.23 (2), p.406-409 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Clonal chromosomal abnormalities in [CD34.sup.+]/[CD38.sup.-] hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitorsBumm, T ; Deininger, J ; Newell, A.H ; Lawce, H ; Olson, S ; Mauro, M ; Druker, B ; Deininger, MLeukemia, 2010-08, Vol.24 (8), p.1525 [Periódico revisado por pares]Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Clonal chromosomal abnormalities in CD34 super(+)/CD38 super(-[/supersc ript] hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors)Bumm, T ; Deininger, J ; Newell, A H ; Lawce, H ; Olson, S ; Mauro, M ; Druker, B ; Deininger, MLeukemia, 2010-08, Vol.24 (8), p.1525-1528 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Ponatinib in Refractory Philadelphia Chromosome–Positive LeukemiasCortes, Jorge E ; Kantarjian, Hagop ; Shah, Neil P ; Bixby, Dale ; Mauro, Michael J ; Flinn, Ian ; O'Hare, Thomas ; Hu, Simin ; Narasimhan, Narayana I ; Rivera, Victor M ; Clackson, Tim ; Turner, Christopher D ; Haluska, Frank G ; Druker, Brian J ; Deininger, Michael W.N ; Talpaz, MosheThe New England journal of medicine, 2012-11, Vol.367 (22), p.2075-2088 [Periódico revisado por pares]Waltham, MA: Massachusetts Medical SocietyTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureHughes, Timothy P ; Mauro, Michael J ; Cortes, Jorge E ; Minami, Hironobu ; Rea, Delphine ; DeAngelo, Daniel J ; Breccia, Massimo ; Goh, Yeow-Tee ; Talpaz, Moshe ; Hochhaus, Andreas ; le Coutre, Philipp ; Ottmann, Oliver ; Heinrich, Michael C ; Steegmann, Juan L ; Deininger, Michael W.N ; Janssen, Jeroen J.W.M ; Mahon, Francois-Xavier ; Minami, Yosuke ; Yeung, David ; Ross, David M ; Tallman, Martin S ; Park, Jae H ; Druker, Brian J ; Hynds, David ; Duan, Yuyan ; Meille, Christophe ; Hourcade-Potelleret, Florence ; Vanasse, K. Gary ; Lang, Fabian ; Kim, Dong-WookThe New England journal of medicine, 2019-12, Vol.381 (24), p.2315-2326 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE TrialCortes, Jorge E ; Gambacorti-Passerini, Carlo ; Deininger, Michael W ; Mauro, Michael J ; Chuah, Charles ; Kim, Dong-Wook ; Dyagil, Irina ; Glushko, Nataliia ; Milojkovic, Dragana ; le Coutre, Philipp ; Garcia-Gutierrez, Valentin ; Reilly, Laurence ; Jeynes-Ellis, Allison ; Leip, Eric ; Bardy-Bouxin, Nathalie ; Hochhaus, Andreas ; Brümmendorf, Tim HJournal of clinical oncology, 2018-01, Vol.36 (3), p.231-237 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid LeukemiaMoslehi, Javid J ; Deininger, MichaelJournal of clinical oncology, 2015-12, Vol.33 (35), p.4210-4218 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaHochhaus, A ; Baccarani, M ; Silver, R T ; Schiffer, C ; Apperley, J F ; Cervantes, F ; Clark, R E ; Cortes, J E ; Deininger, M W ; Guilhot, F ; Hjorth-Hansen, H ; Hughes, T P ; Janssen, J J W M ; Kantarjian, H M ; Kim, D W ; Larson, R A ; Lipton, J H ; Mahon, F X ; Mayer, J ; Nicolini, F ; Niederwieser, D ; Pane, F ; Radich, J P ; Rea, D ; Richter, J ; Rosti, G ; Rousselot, P ; Saglio, G ; Saußele, S ; Soverini, S ; Steegmann, J L ; Turkina, A ; Zaritskey, A ; Hehlmann, RLeukemia, 2020-04, Vol.34 (4), p.966-984 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid LeukemiaHochhaus, Andreas ; Larson, Richard A ; Guilhot, François ; Radich, Jerald P ; Branford, Susan ; Hughes, Timothy P ; Baccarani, Michele ; Deininger, Michael W ; Cervantes, Francisco ; Fujihara, Satoko ; Ortmann, Christine-Elke ; Menssen, Hans D ; Kantarjian, Hagop ; O’Brien, Stephen G ; Druker, Brian JThe New England journal of medicine, 2017-03, Vol.376 (10), p.917-927 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |